Karyopharm Therapeutics Inc. Effect of Exchange Rate on Cash, Continuing Operations
Karyopharm Therapeutics Inc. (KPTI) reported Effect of Exchange Rate on Cash, Continuing Operations of -$11.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashContinuingOperations · last filed 2015-05-11
- Karyopharm Therapeutics Inc. effect of exchange rate on cash, continuing operations for the quarter ending 2015-03-31 was -$11.00K.
- Karyopharm Therapeutics Inc. effect of exchange rate on cash, continuing operations for fiscal 2014 was -$8.00K.
| Period end | Effect of Exchange Rate on Cash, Continuing Operations 3 month | Effect of Exchange Rate on Cash, Continuing Operations 12 month |
|---|---|---|
| 2015-03-31 | -$11.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$8.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |